… trials of ADT combined with other treatments … novel hormonal therapies—abiraterone, enzalutamide, … drugs/fda-approves-enzalutamide-non-metastatic-castration-sensitive-prostate-cancer … and Western medicine for castration-resistant prostate cancer. Zhonghua …

… Madison Vaccines, Johnson & Johnson Innovative Medicine (Janssen Pharmaceuticals), Pfizer … Prostate Cancer Competitive Landscape Some of the CSPC drugs in clinical trials … for Medical Oncology (ESMO) Treatment Recommendations for Prostate Cancer (2023 …

… treatment and sustain adherence among patients with metastatic castration-sensitive prostate cancer … practical experience and nuanced drug characteristics. To support adherence … management. Panelists noted that abiraterone, apalutamide, and enzalutamide …

… supporting long-term treatment of urgency urinary incontinence. News release. BlueWind Medical. December 16, … fda.gov/drugs/;resources-information-approved-drugs/fda-grants-regular-approval-rucaparib-metastatic-castration-resistant-prostate-cancer

… chemotherapy, incomplete medical records or death within the first 30 days after treatment … MR, et al. Abiraterone for prostate cancer not previously treated with hormone … phase 3 trial of chemoradiotherapy in patients with high-risk prostate cancer: NRG …

… genitourinary medical oncology and division of cancer medicine at … lowering therapies, including statins and appropriate blood … (22%). Common treatments for prostate cancer, such as androgen … Janssen), with or without abiraterone (Zytiga, Janssen). At …

… of ARPIs, including abiraterone acetate (Zytiga), … drug interactions and monitoring requirements. Docetaxel chemotherapy … in managing advanced prostate cancer. Medical oncologists, urologists, … the treatment landscape for advanced prostate cancer is …

… niraparib and abiraterone acetate (Akeega) plus prednisone for the treatment of adult … prostate cancer (mCSPC). The FDA has approved T-DXd plus pertuzumab (Perjeta) for the treatment … HER2-targeting antibody-drug conjugate, for the treatment of adult patients …

… Drug makers are exploring radioligand therapies, gene-based treatments, and vaccine- … December: The FDA approved AKEEGA (niraparib and abiraterone acetate) as the … Prostate Cancer Treatment Market is undergoing a crucial transformation driven by medical …

… associated metastatic castration-resistant prostate cancer (mCRPC) previously treated … will be posted on Drugs@FDA.  Safety and Efficacy … received (enzalutamide or abiraterone acetate) or docetaxel. … of testosterone via treatment with androgen deprivation …